Tokyo, Aug. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058698) titled 'A single center, retrospective study of the ECG-guided method using Sherlock 3CG system for PICC insertion' on Aug. 6.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Sapporo Medical University
Condition:
Condition - The patients who were inserted Power PICC by using Sherlock 3CG system
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - We are going to perform the retrospective study to analyze the data from 2019.1 to 2025. 4 about the patients who were inserted Power PICC by using Sherlock 3CG in our department.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - The patients who were inserted Power PICC by using Sherlock 3CG from 2019.1 to 2025.4 in our department.
Key exclusion criteria - Patients who expressed their refusal to participate in this study through the publicly disclosed opt-out document
Target Size - 100
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 06 Month 20 Day
Date of IRB - 2025 Year 07 Month 10 Day
Anticipated trial start date - 2025 Year 07 Month 10 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067066
Disclaimer: Curated by HT Syndication.
